WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

NovaDel Pharma, Inc. - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 61

NovaDel Pharma, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “NovaDel Pharma, Inc. - Product Pipeline Review - H2 2011” provides data on the NovaDel Pharma, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, NovaDel Pharma, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from NovaDel Pharma, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- NovaDel Pharma, Inc. - Brief NovaDel Pharma, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NovaDel Pharma, Inc. human therapeutic division.
- Overview of pipeline therapeutics across v



List of Tables
List of Figures
NovaDel Pharma, Inc. Snapshot
NovaDel Pharma, Inc. Overview
Key Information
Key Facts
NovaDel Pharma, Inc. – Research and Development Overview
Key Therapeutic Areas
NovaDel Pharma, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
NovaDel Pharma, Inc. – Pipeline Products Glance
NovaDel Pharma, Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
NovaDel Pharma, Inc. Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
NovaDel Pharma, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
NovaDel Pharma, Inc. – Drug Profiles
NVD-201
NVD-301
NVD-501
Zolpimist
NovaDel Pharma, Inc. – Pipeline Analysis
NovaDel Pharma, Inc. – Pipeline Products by Therapeutic Class
NovaDel Pharma, Inc. - Pipeline Products By Target
NovaDel Pharma, Inc. – Pipel

Customers who bought this item also bought